|
mslosar
about 1 year
ago
|
Ample research demonstrates the positive benefits of nutritional supplements, particularly Omega-3 fatty acids, as an adjunct to standard pharmacotherapy in the care and treatment of our patients, particularly those with age-related macular degeneration (AMD) and dry eye syndrome (DES).
With so much recent evidence (see some of the studies posted at the bottom of this posting) suggesting that nutritional supplements may play a role in the prevention and treatment of several ophthalmic diseases, we as health care providers must ask ourselves, “What is our role in this industry?”
As a private practice eye doctor for 30 years, I now work with other eye doctors and their staff to set up the turn-key implementation steps to incorporate high quality, pharmaceutical grade nutritionals supplements into your practice to enhance patient care and, at the same time, add practice revenues to the bottom line. You or your staff may call for more information.
Mark Slosar, O.D., F.A.A.O.
cell 949-310-9926
mark@drmarkslosar.com
Journal of Clinical Nutrition, August 2008, Dietary Omega-3 fatty acids can reduce age-related macular degeneration.
Archives of Ophthalmology (2001, diets high in Omega-3 and fish were inversely associated with risk for AMD when intake of linoleic acid was low.
US Twin Study of AMD found Omega-3 fatty acid intake reduced the risk of AMD.
Archives of Ophthalomogy, June 2008, high dietary intake of Omega-3 was assciated with an overall 38% reduction in risk of late AMD.
Lutein Antioxidant Supplementation Trial (LAST Study), 2004, visual function improved with lutein alone or together with antioxidants, vitamins, and minerals in male patients with atrophic AMD.
TOZAL Study, BMC Ophthalomogy 2007, demonstated stabilization or improvement of BCVA at 6 months in 76% of patients.
Women’s Health Study found a 68% reduction of dry eye syndrome in women who consumed five to sex servings of tuna per week.
|